Home Health Billing Under PDGM: Where 30-Day Periods Quietly Cost You Revenue

Home health billing under PDGM doesn’t fail the way other specialties fail. There’s usually no denial to chase. The claim pays, just at a lower rate than it should have, because a functional impairment score wasn’t fully supported, a comorbidity code never made it onto the claim, or a visit count slipped under the LUPA threshold nobody was tracking.

In our experience working with home health agencies since PDGM’s rollout, this quiet underpayment adds up to more lost revenue over a year than outright denials do. It doesn’t show up on a denial report because technically, nothing was denied. It shows up as a lower average payment per period than the agency’s actual clinical mix should generate.

This guide breaks down exactly where 30-day periods lose revenue and what to check before, not after, each period closes.

PDGM Basics: How a 30-Day Period Gets Its Payment Rate

Every 30-day period’s payment depends on four factors: admission source (community or institutional), clinical grouping based on the principal diagnosis, functional impairment level from the OASIS assessment, and comorbidity adjustment from qualifying secondary diagnoses. Get any one of these wrong, and the period’s case-mix weight, and therefore its payment, comes in lower than the patient’s actual clinical picture supports.

Unlike the old 60-day episode model, PDGM treats each 30-day period as its own scoring event. A patient’s second period doesn’t inherit the first period’s admission source designation or functional score. Every period needs its own accurate documentation, which means the revenue risk repeats every 30 days for the length of the care plan, not just once at intake.

Where PDGM Revenue Actually Leaks

None of these show up as a rejected claim. They show up as a paid claim at a lower rate, which is exactly why they’re so easy for an agency to miss month after month.

The LUPA Threshold: Where Visit Counts Quietly Cut Payment

LUPA thresholds aren’t a single number across all patients. A period grouped under a higher-acuity clinical category with a higher functional impairment score has a different threshold than a lower-acuity period. Agencies that track visit counts against a single flat number, rather than each period’s specific threshold, either scramble to add an unnecessary visit near period-end or miss the risk entirely and get hit with a LUPA they didn’t see coming.

The fix is visibility earlier in the period, not at the end. Flagging a period at visit 3 of a 4-visit threshold with two weeks still remaining gives clinical staff time to confirm whether an additional visit is clinically appropriate, rather than discovering the shortfall after the period has already closed.

Functional Impairment Scoring: Where OASIS Accuracy Directly Sets Payment

The functional impairment component of PDGM’s case-mix weight comes directly from specific OASIS items covering mobility, self-care, and other functional domains. If those items get scored lower than the patient’s actual limitations, either through rushed assessment or unfamiliarity with OASIS scoring guidance, the period pays less than it should, and there’s no downstream mechanism that catches or corrects it.

The opposite risk matters too. Overscoring functional impairment beyond what the clinical documentation supports elsewhere in the chart creates an audit and recoupment risk. The goal isn’t to maximize the score, it’s to make sure the OASIS assessment accurately reflects the same clinical picture documented in the visit notes, so the payment matches the actual care being delivered.

Comorbidity Adjustment: The Revenue Sitting in the Chart But Not on the Claim

PDGM adds a payment adjustment for qualifying comorbidities, low, high, or none, based on secondary diagnoses reported on the claim. The gap here is common and specific: a patient’s chart clearly documents a qualifying condition, like diabetes with complications or a chronic respiratory condition, but that diagnosis never makes it onto the actual claim submission because the coding process pulled only the primary diagnosis and a couple of obvious secondaries.

This is a coding thoroughness issue, not a clinical documentation issue in most cases. The information exists. It just doesn’t make it through to the claim. A structured secondary diagnosis review, comparing the full problem list against what actually gets submitted, catches this before the period bills.

Admission Source: A Simple Field With Outsized Payment Impact

Institutional admission source, meaning the patient came from a hospital, skilled nursing facility, or inpatient rehab stay within 14 days of home health start, generally pays more than community admission for an otherwise identical clinical and functional profile. Agencies that don’t verify the referral source carefully at intake, or that default to community admission when the actual source is ambiguous, underbill periods that qualified for the higher institutional rate.

Verifying admission source takes one phone call or referral record check at intake. Skipping that step because it seems like a minor administrative detail is one of the simplest, most avoidable ways agencies leave PDGM revenue on the table.

Clinical Grouping: The Diagnosis Code Choice That Sets the Foundation

Before functional score or comorbidity adjustment even come into play, the principal diagnosis reported determines which of PDGM’s clinical groupings a period falls into, and that grouping sets the baseline case-mix weight everything else builds on. Two patients with genuinely similar overall clinical pictures can land in different groupings, and therefore different baseline payment rates, depending entirely on which diagnosis gets listed as principal versus secondary.

This isn’t about picking a higher-paying code that doesn’t reflect the patient’s condition. It’s about making sure the principal diagnosis selected is the one that most accurately drove the need for home health services in the first place, based on physician documentation, rather than defaulting to whatever diagnosis appears first on a referral form. A referral form’s diagnosis order often reflects hospital discharge paperwork conventions, not necessarily the clinical focus of the home health plan of care.

Post-Payment Review Risk and Why Overcorrection Isn’t the Answer

Everything in this guide is about capturing revenue the clinical documentation genuinely supports, not about pushing scores or codes higher than the chart justifies. CMS runs post-payment reviews on home health claims, and a pattern of consistently high functional impairment scores or comorbidity adjustments that don’t hold up against the clinical record triggers exactly the kind of audit scrutiny that costs an agency far more than the underpayment it was trying to avoid.

The safest approach treats accurate documentation as the goal, with correct payment as the natural result, rather than treating payment optimization as the goal with documentation as something to justify it after the fact. Agencies that get this backward tend to see a short-term revenue bump followed by a much larger recoupment risk once a review catches the pattern.

Cost of Inaction: What These Leaks Actually Cost Over a Year

A mid-size home health agency running 300 active 30-day periods a month, with even a 15% average underpayment across comorbidity gaps, functional scoring, and admission source errors, is looking at a meaningful percentage of total case-mix revenue left uncollected every single month. Because none of it shows up as a denial, most agencies don’t discover the full scope of this until a retrospective revenue audit compares actual payments against what the clinical documentation should have supported.

Unlike a denied claim, a PDGM underpayment on a paid claim generally can’t be corrected after the fact except through a formal claim adjustment request, which many agencies don’t pursue because the per-period dollar difference looks small in isolation. Multiplied across hundreds of periods a month, it isn’t small at all.

In-House vs. Outsourced PDGM Revenue Management

Filing a Claim Adjustment for an Underscored Period

When a retrospective review finds a period was underscored, meaning the clinical documentation supports a higher functional level or an uncaptured comorbidity that never made it onto the original claim, a claim adjustment request can correct it after the fact, within CMS’s timely filing rules. This isn’t the same as an appeal, since there’s no denial being contested. It’s a correction to a paid claim based on documentation that existed at the time but wasn’t reflected in the original submission.

The adjustment needs to reference the specific OASIS item or diagnosis that was missed, along with the supporting chart documentation. Agencies that skip this step because the per-period dollar amount looks small individually are leaving real money on the table, since these adjustments are often approved without much friction when the documentation clearly supports the correction.

How Qualigenix Protects PDGM Revenue

We review each period’s admission source, functional impairment documentation, and comorbidity list against the full clinical chart before the claim goes out, not after the remittance comes back lower than expected. Visit counts get tracked against each period’s specific LUPA threshold with enough lead time for clinical staff to make an informed decision, not a last-minute scramble.

Where a claim adjustment request is warranted for a genuinely underscored or undercoded period, we file it, since most agencies don’t have the staff time to pursue every eligible correction on their own.

What Agency Directors Say About Working With Qualigenix

10-Point PDGM Revenue Protection Checklist

• ☐ Verify admission source against referral records at intake, not assumption
• ☐ Cross-check OASIS functional scores against visit note documentation
• ☐ Review the full problem list for uncaptured comorbidity codes before submission
• ☐ Track visit counts against each period’s specific LUPA threshold, not a flat number
• ☐ Flag LUPA risk with at least two weeks remaining in the period
• ☐ Score every 30-day period independently, without assuming carryover accuracy
• ☐ Initiate recertification cleanly at each period boundary to avoid timing gaps
• ☐ File claim adjustment requests for confirmed underscored periods
• ☐ Run a quarterly revenue audit comparing paid amounts against clinical documentation
• ☐ Train intake and coding staff jointly on PDGM’s four scoring factors

Frequently Asked Questions

What is PDGM in home health billing?

How many 30-day periods can a patient have?

What is the LUPA threshold under PDGM?

How does admission source affect payment?

What happens if OASIS documentation doesn’t support the functional score?

How does comorbidity adjustment work?

What’s the revenue risk from a recertification timing gap?

Training Clinicians on the Payment Connection Without Distorting Care

Field clinicians completing OASIS assessments are focused on the patient in front of them, not the case-mix calculation their answers feed into, and that’s exactly how it should be. The goal of training isn’t to teach clinicians to score for payment, it’s to close the gap between how they actually observe a patient’s functional status and how precisely that observation gets translated into the specific OASIS item language CMS uses to calculate the score.

A clinician who watches a patient struggle significantly with a mobility task but marks a moderate rather than severe impairment level, simply because the item’s specific wording wasn’t fully considered in the moment, isn’t making a clinical error. They’re making a documentation precision error that costs the agency real revenue on a patient whose actual needs were accurately observed but imprecisely recorded. Short, periodic OASIS scoring refreshers, focused on item-specific language rather than general assessment skills, close this gap without turning clinical documentation into a payment-chasing exercise.

Related Resources

• Medical Billing Services
• Home Health Billing Services
• Denial Management